← Back to signals
GILD
STRONG BUYGilead Sciences Inc.
Health Care
0.65
PEGY ratio
Rank #70
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 30.4% annually over 5 years. Pays a 2.5% dividend yield.
GILD is trading at 17.8x earnings against 25.0% capped growth (actual 30.4%) + 2.5% yield, giving a PEGY of 0.65. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 30.4%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-02
Valuation
17.8x
P/E Ratio
Growth
30.4%
5yr EPS
Income
2.5%
Div Yield
PEGY Components
PEGY Score0.65
Denominator27.5%
EPS (TTM)$7.35
Market Data
Price$131.10
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
0.67→0.65(-0.02)
Rank
#80→#70(+10 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only